Identifying the mechanisms of action driving a drug’s anti-cancer efficacy is critical for identifying optimal biomarkers, indications, and combinations for clinical success. Yet, systematically ...

The GNPS Drug Library may be more broadly applicable for drug screening across diverse research disciplines, such as food and environmental monitoring.

A meta-analysis of 80,737 cases identifies five new variants and 22 risk genes, highlighting three potential drug targets for ...

Abivax receives a "Strong Buy" rating, driven by positive phase 3 ABTECT induction data for obefazimod in moderate-to-severe ...

New findings out of King’s College London suggest that certain fiber-rich foods may help improve motility, soften stool, and ...

Crofelemer can potentially extend lives of MVID patients – infants and children who face the lethal natural history of the disease Parenteral support reduction of up to 37% is groundbreaking; No ...

An update from SinoMab Bioscience Ltd. ( ($HK:3681) ) is now available. SinoMab BioScience Limited announced that its Investigational New Drug ...

What if the race to get thin was quietly putting health at risk? That question is becoming harder to ignore as glucagon‑like ...

A new oral GLP-1 receptor agonist, orforglipron, is revolutionizing weight management by offering a needle-free alternative ...

Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM ESTCompany ParticipantsDietmar Berger - Chief ...

In 2024, the U.S. FDA granted HYRNUO Breakthrough Therapy designation for the treatment of adult patients with unresectable or metastatic NSCLC whose tumors have activating HER2 (ERBB2) mutations, and ...

Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is a chronic, relapsing inflammatory disorder of the gastrointestinal ...